Tenderwize
Retour à la recherche

Colistin Discount Agreement (Open-House)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2027 · 309 days left·Open·Supplies·Framework
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Colistin (ATC-Code: J01XB01).

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

The open-house contracts can be terminated automatically without notice when exclusive agreements are awarded (expected...

No minimum purchase or volume commitment. The agreement is only a discount framework; actual sales depend on prescripti...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Conclusion of non-exclusive discount agreements for Colistin (ATC J01XB01) with pharmaceutical companies.
  • Open-house model with standardized contract terms and conditions.
Afficher le résumé complet

This notice announces a non-exclusive discount agreement (Rabattvertrag) for the active substance Colistin (ATC J01XB01) under § 130a Abs. 8 SGB V, following an 'open-house' model. The AOK Niedersachsen invites all interested pharmaceutical companies to conclude standardized discount contracts without a competitive selection process. The contract runs from 01.09.2025 to 31.08.2027, with potential monthly entry and early termination if exclusive contracts are awarded. No estimated value is provided. The notice explicitly states this is not a public procurement under EU directives but is published for transparency.

Risques

The open-house contracts can be terminated automatically without notice when exclusive agreements are awarded (expected...

No minimum purchase or volume commitment. The agreement is only a discount framework; actual sales depend on prescripti...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG with respect to the offered medicinal products.
  • Must have a seat in Germany, another EU member state, or an EEA state (§ 9 Abs. 2 Satz 1 AMG).

Administrative

  • Submission of contract documents in paper form (electronic submission not allowed).

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Award based solely on price (discount offered).

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Colistin Discount Agreement (Open-House)

Non-exclusive discount contract for Colistin (ATC J01XB01) with standardized terms. Pharmaceutical companies can join at any time, subject to the maximum contract period ending 31.08.2027. Contracts may be replaced by exclusive agreements awarded later.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Aug 2025 - Aug 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Jun 27, 2027

Détails de la procédure

Date de publication
08 Jul 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
447775-2025

Appels d'offres similaires